申请人:——
公开号:US20020111317A1
公开(公告)日:2002-08-15
The present invention provides novel sixteen-membered macrolide compounds that are useful as anti-infective agents or as intermediates thereto. The present invention also provides methods for the preparation of these compounds, and methods and formulations for their use. In one aspect of the present invention, sixteen-membered macrolide possessing a side chain Z are provided where Z is aliphatic, aryl, alkylaryl, halide, ═NOR
3
, ═NNHR
3
, or —W—R
3
where W is O, S, NC(═O)R
4
, NC(═O)OR
4
, NC(═O)NHR
4
or NR
4
where R
3
and R
4
are each independently hydrogen, aliphatic, aryl or alkylaryl. In another aspect of the present invention, bicyclic compounds are provided where one of the cyclic-components is a sixteen-membered macrolide and the other is a cyclic moiety whose cyclic structure is formed by between 3 and 10 atoms. In another aspect of the present invention, sixteen-membered macrolide compounds that bind to the domain II region of the 23S RNA are provided.
本发明提供了新型的十六元大环内酯化合物,可用作抗感染药物或其中间体。本发明还提供了制备这些化合物的方法,以及它们的使用方法和配方。在本发明的一个方面,提供了具有侧链Z的十六元大环内酯,其中Z是脂肪族、芳香族、烷基芳基、卤素、═NOR3、═NNHR3或—W—R3,其中W为O、S、NC(═O)R4、NC(═O)OR4、NC(═O)NHR4或NR4,其中R3和R4各自独立地为氢、脂肪族、芳香族或烷基芳基。在本发明的另一个方面,提供了双环化合物,其中一个环组分是十六元大环内酯,另一个是由3至10个原子形成的环状基团。在本发明的另一个方面,提供了与23S RNA的II区域结合的十六元大环内酯化合物。